Dolby Laboratories (NYSE:DLB) SVP Sells $460,020.00 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $60.00, for a total transaction of $460,020.00. Following the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at $7,123,620. The trade was a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Dolby Laboratories Stock Performance

Shares of NYSE:DLB opened at $61.70 on Friday. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $75.66. The firm has a market cap of $5.78 billion, a PE ratio of 26.26 and a beta of 0.80. The firm’s fifty day moving average is $52.82 and its 200-day moving average is $58.49.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.Dolby Laboratories’s quarterly revenue was down 3.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Sell-side analysts forecast that Dolby Laboratories will post 3.21 EPS for the current year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is 61.28%.

Dolby Laboratories declared that its board has approved a share buyback program on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to purchase up to 7% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.

Institutional Trading of Dolby Laboratories

Several hedge funds have recently modified their holdings of DLB. Fifth Third Bancorp increased its stake in Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares in the last quarter. Aquatic Capital Management LLC bought a new position in shares of Dolby Laboratories during the 3rd quarter worth about $56,000. iSAM Funds UK Ltd acquired a new stake in shares of Dolby Laboratories in the 3rd quarter valued at about $68,000. Quarry LP increased its position in Dolby Laboratories by 1,486.7% in the 4th quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after buying an additional 1,115 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its stake in Dolby Laboratories by 48.4% during the 4th quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock worth $79,000 after buying an additional 402 shares during the period. Institutional investors own 58.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on DLB shares. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Finally, Rosenblatt Securities restated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, July 31st. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.